Thursday, June 23, 2016
- 12:00pm-1:30pm
-
Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Brain networks revealed by resting state functional MRI in familial and sporadic primary dystonia
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Can hospital admissions predict mortality in Parkinson’s?
Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Can treadmill training facilitate the dual-task gait in Parkinson’s disease?
Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Categories of psychogenic movement disorders to functional blepharospasm
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Cervical dystonia and quality of life
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Cervical dystonia associated to Wallenberg syndrome
Dystonia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Cervical dystonia preceding Parkinson´s disease – Continuum – coincidence or epiphenomenon–Report of 3 cases
Dystonia · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 53
- Next Page»